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A B S T R A C T
Plastein is a protease-induced peptide aggregate with prospective application in enhancing the
nutritional quality of proteins and debittering protein hydrolysates. These properties are yet to be applied
in product development possibly due to economic considerations (production cost vs. product yields).
This paper reviews currently proposed mechanisms of plastein formation including condensation,
transpeptidation and physical interaction of aggregating peptides. Emerging ﬁndings indicate that
plastein possesses bioactivities, thereby expanding its prospective application. The role of proteases in
inducing peptide interaction in plastein remains unclear. Understanding the protease function will
facilitate the development of efﬁcient proteases and scalable industrial processes for plasteinproduction.
ã 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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1. Introduction
Plastein is formed as gels or thixotropic products from
concentrated peptide mixtures or protein hydrolysates in the
presence of proteases under optimum conditions. The peptide
aggregate was ﬁrst observed by Danilewski in 1886 when stomach
extract was added to concentrated peptic hydrolysates [50]. It was
believed that active enzyme was responsible for precipitation
since heat-inactivated extract did not induce precipitation. A
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decade later, Okunew suggested that the precipitates were newly
synthesized products from protein fragments [50]. The term
“plastein”was proposed in 1901 and its formation was believed to
be a reversal of regular protease-induced protein hydrolysis
through the reformation of peptide linkages [50], since the
decreased free amino nitrogen content associated with plastein
formation was regarded as the reversal of hydrolysis. Moreover,
the aggregate was suggested to be similar to acid-denatured
proteins [5,49–51], although more recent evidence showed
lack of deﬁned structural pattern in plastein as deduced by
differential scanning calorimetry [6]. It was also thought that
plastein could be a mixture of substances, and that its insolubility
and decreased free amino nitrogen content were due to cyclic
anhydride formation [14,15,29]. Many other mechanisms have
been proposed for plastein formation. Themost recentmechanism
involves aggregation through the formation of non-covalent bonds
in interacting peptides [1,38,47,59]. However, the exact role of the
proteases in inducing aggregation remains unclear.
The value of plastein was not realized until the 1970s, several
decades after its discovery. The ﬁrst proposed application of
plastein was focused on the production of high quality food
proteins for nutritional uses. Plastein was explored as a vehicle
for the delivery of essential amino acids and as means of
debittering food protein hydrolysates. Despite the prospects,
industrial application of plastein in food production was not
popular possibly due to challenges associated with yield and cost
of production, and these may have contributed to stagnation of
interest on the peptide aggregates. However, recent efforts have
rekindled interest in plastein research with the observation of
its biological activity related to human health promotion. It is
known that the chemical and physical properties of peptides are
greatly altered after plastein reaction. Particularly, viscosity and
molecular weight are increased in plastein [22,53], and this can
result in alteration of bioactivities associated with native
molecular peptide structures.
2. Proposed mechanisms of plastein formation
The mechanism of plastein formation has not been completely
elucidated. Plasteinwas ﬁrst thought to be a resynthesized protein
based on the decrease in free amino nitrogen content and absence
of precipitate formation when inactivated protease was used
[7,48]. However, it was also thought that the precipitates are
formed as a result of denaturation of high molecular weight
substances in the hydrolysis product [7,25]. Subsequently, a
number of mechanisms have been proposed for plastein formation
including peptide condensation, transpeptidation and aggregation
induced by physical forces.
2.1. Peptide condensation
In a bid to debitter and increase the nutritional value of protein
hydrolysates, Yamashita et al. [58] found that L-methionine
derivatives can be incorporated into soy hydrolysates using papain
to form plastein; the authors suggested the formation of peptide
bonds during the reaction between the amino acids and protein
[(Fig._1)TD$FIG]
Fig. 1. (A) Amino acid composition, (B) total and (C) major hydrophobic and hydrophilic amino acid residues (molar%) of mycoprotein hydrolysates, its platein pellet and
residual peptides in supernatant after plastein isolation (total hydrophobic: Pro, Ala, Val, Cys, Met, Ile, Leu, Tyr, Phe; total hydrophilic: Asx, Glx, Lys, His, Arg; major
hydrophobic: Val, Ile, Leu, Phe; major hydrophilic: Asx, Glx, Lys, Arg); amino acid composition was obtained from Brownsell et al. [6].
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hydrolysates. Condensation was not observed with free amino
acids and was successful only with peptides or amino acid ethyl
esters [58]. The peptide condensation mechanism can be
supported by the decreased free amino nitrogen content,
appearance of higher molecular weight complexes and increased
viscosity observed in plastein compared to their protein hydroly-
sate precursors [22,47,57,61]. A study with nuclear magnetic
resonance spectroscopy and electrospray mass spectroscopy in a
model system provided evidence of oligopeptide formation from
condensation of smaller hydrophobic synthetic peptides, although
the phenomenon could not be conﬁrmed to occur to the same
extent in complex protein hydrolysate system [37]. Furthermore,
blocking the amino and carboxyl terminals of peptides was
demonstrated to only slightly lower plastein yield [1], indicating
the possibly minor role of peptide condensation and existence of
other mechanisms of plastein formation.
2.2. Transpeptidation
Some studies have found that the amount of amino nitrogen
remained unchanged with elevated hydrophobic amino acid
residues during the formation of egg albumin and soy
protein-derived plastein [23,54]. Van Hofsten and Lalasidis [48]
reported the absence of high molecular weight product in
whey and ﬁsh protein-derived plastein, whereas other studies
reported the formation of low- and high-molecular weight peptide
complexes during plastein reaction [8]. Based on these ﬁndings,
transpeptidation was proposed to be partially responsible for
plastein formation [17,20,54]. Transpeptidation is a process
involving peptide bond breakage and formation resulting in the
rearrangement of amino acid residues. Therefore, amino acid
residues are transferred from one peptide sequence to another
leading to accumulation of hydrophobic amino acid residues in
some peptides and subsequent formation of hydrophobic core and
aggregation of the peptides. Transpeptidation was believed to
occur with condensation during plastein synthesis [12] and this
was supported by the observation of new and rearranged
peptides in model systems [37]. However, the selectivity of
transpeptidation in rearranging speciﬁc amino acid residues, and
mechanism of protease-induced peptide bond breakage and
formation (characteristic of transpeptidation) during plastein
reaction are not apparent from the studies discussed above.
2.3. Physical forces in peptide aggregation
Andrews and Alichanidis observed that there was no substan-
tial qualitative difference in peptide composition of resolubilized
plastein and the starting hydrolysates. This ﬁnding indicated that
new peptides may not be synthesized during plastein formation as
suggested by gel electrophoresis and preliminary small-angle
neutron scattering experiments [1]. Moreover, plastein formation
was found in the study to proceed even after enzyme inactivation
albeit at a slower rate. These evidences eliminate condensation and
transpeptidation as the major mechanisms of plastein synthesis. It
was then suggested that aggregation during plastein reaction
could be entropy-driven as a result of non-covalent interaction
of hydrophobic and ionic regions of the peptides [1,37]. The
hydrophobicity mechanism was supported by the observation of
increased afﬁnity of plastein for a hydrophobic probe, and over 98%
decrease in turbidity of aqueous plastein suspension in the
presence of a surfactant (2mM sodium dodecyl sulfate), which
would disrupt the hydrophobic bonds that hold the plastein
structure together [3,47]. High ionic strength solutions were found
to have little or no effect on plastein turbidity, indicating theminor
role of ionic interaction in the aggregate formation [40,47,48]. The
hydrophobic interaction mechanism is highly plausible as isolated
mycoprotein-derived plastein pellets were found to contain higher
molar% of hydrophobic amino acids (Val, Leu, Met, Phe, Ile) and
lower amounts of hydrophilic amino acids compared to its
hydrolysates precursor and unincorporated peptides in the
plastein supernatant [6], as shown in Fig. 1A–C. Therefore,
selection of protein precursors rich in hydrophobic amino
acid residues can be pursued for the production of high plastein
yields. Although hydrophobicity-induced aggregation is the most
currently accepted and plausible mechanism, there is still a
knowledge gap on the speciﬁc role of proteases in inducing
non-covalent peptide interactions during plastein formation.
3. Plastein production
As shown in Fig. 2, the method of plastein production usually
consists of three steps: (1) protein hydrolysis by proteases at low
substrate concentration (3–5%, w/v); (2) concentration of protein
hydrolysates by freeze-drying or evaporation, and (3) plastein
formation by incubating high concentration of the protein
hydrolysateswith same or different protease [10]. Plastein reaction
usually occurs at substrate concentrations of 30–50% (w/v),
optimally at 40%, and at pH and temperature ranges from
3.0–7.0 to 37–50 C, respectively. The optimum temperature and
pH are not necessarily for the enzymatic activity during hydrolysis.
It is recommended that the same protease be used for the protein
hydrolysis and plastein formation steps in order to avoid further
proteolysis during plastein reaction, which can decrease plastein
yield [39]. Depending on conditions of incubation, the reaction
time for plastein formation can range from 24 to 72h [12],
although the aggregates have also been produced during shorter
durations [47,61,63]. Repeated washing was found to solubilize
plastein in aqueous solution; therefore, plastein formation was
considered to be reversible although the aggregate can be
precipitated as insolublematerial [1]. Proteases that are commonly
[(Fig._2)TD$FIG]
Fig. 2. The reaction steps in protease induced-aggregation during plastein formation.
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used for protein hydrolysis and subsequent plastein reaction
include papain, pepsin, a-chymotrypsin and trypsin; although
there is currently no supporting mechanism, pepsin is considered
the most effective for producing high yields of plastein with high
gel strength especially near neutral pH [18,52,55]. Furthermore,
inactivated proteases can catalyze plastein formation to some
extent resulting in low product yield; thus, native active proteases
are preferred for plastein production [1].
In general, proteinogenic amino acids have the potential to form
plastein under optimum conditions but those with hydrophobic
side chains are more likely to be easily incorporated into plastein
[3,12]. Several protein-containing agricultural and food materials
have been utilized as substrates for plastein formation including
soybean, plant leave proteins, zein, wheat, egg albumin, milk, corn,
mycoprotein, squid, ﬁsh and ﬁsh silage [4,11,24,30,31,34,36,39,52].
4. Factors that inﬂuence plastein formation
The major factor that inﬂuences plastein formation is the
substrate (protein hydrolysates or oligopeptide mixture) concen-
tration [17,44,52]. For instance, plastein yield from mycoprotein
hydrolysates produced with pepsin (enzyme–substrate ratio,
E/S 1:100, pH 5.0, 37 C) was found to increase exponentially
from about 4 to 13% with respective peptide concentrations of
11–43% (w/w) [52]. Therefore, higher substrate content enhances
peptide proximity, which encourages entropy-driven aggregation
of the hydrophobic peptides [52]. In fact, low substrate concen-
tration has been found to promote enzymatic hydrolysis instead of
peptide aggregation [17,44]. Moreover, the low-molecular weight
of peptides has been shown to promote plastein formation.
Fujimaki et al. [17] reported that increase in degree of hydrolysis
resulted in higher yields of plastein produced from protein
hydrolysates using microbial proteases. This was thought to be
due to the requirement of free amino acids or small peptides for
condensation and elongation [48], considering the plausible roles
of these reactions in promoting the formation of plastein. However,
the effect of increased hydrolysis on plastein yield was found to be
independent of plastein reaction time, although substantial
decrease in gel strength was observed during long (24h) duration
[11]. This suggests that higher molecular weight peptides can also
form plastein but formation of stronger aggregate is favored with
smaller peptide precursors. Sukan and Andrews [39] reported a
peptide molecular size range of 400–800Da for obtaining the
highest plastein yield for pepsin–casein hydrolysates reaction, and
Williams et al. [52] noted that further decrease in peptide size
due to extensive hydrolysis (as observed with pronase) would
likely not support plastein synthesis. It is possible that the ability of
peptides to form plastein is related to the amount of their
constituent hydrophobic amino acid residues, which are less likely
to occur within a given peptide after extensive protein hydrolysis.
The relationship between peptide molecular size and plastein
yield still needs to be clearly deﬁned.
Plastein reaction has been found to readily occur with peptides
and less likely betweenpeptides and free amino acids. Based on the
condensation mechanism, the energy required to form a peptide
bond for peptides (0.4 kcal/mol) is far less than that required for
free amino acids (4 kcal/mol) [12], although the condensation
mechanism in plastein formation appears thermodynamically
unfavorable [1,37,48]. Based on energy requirements, earlier
studies utilized amino acid ethyl esters for plastein formation
with different proteins instead of free amino acids [4,16,57].
Moreover, hydrophobic amino acids appear more likely to be
incorporated into plastein than hydrophilic amino acids,
although highly hydrophobic amino acids present a challenge of
precipitating before the occurrence of plastein reaction [3]. The
incorporation of non-hydrophobic amino acids into plastein can be
enhanced by alkylation. For instance, ethylation of the a- and
g-carboxyl groups of Glu enhanced its incorporation into soy
globulin [59]. Furthermore, the type of protein starting material
can also impact plastein yield. For instance, pepsin-induced
plastein formation in mycoprotein and casein hydrolysates
yielded 13% and 27% of aggregate products, respectively, under
similar reaction conditions [39,52]. This observation may be
due to differences in the hydrophobicity of the proteins and the
resulting enzymatic hydrolysates.
The pH of reaction medium has been shown to impact plastein
reaction. The optimum pH for enzymatic activity is needed for
protein hydrolysis whereas the highest plastein yields are obtained
at different pH ranging from 3.0 to 11.0, depending on the protease
[12,17]. Contraryobservations havebeen reportedwhere theyield of
mycoprotein-derived plastein varied at pH 3.0–7.5 [52], and it
appears that the substrate type, protease and reaction conditions
may have contributed to the discrepancies. Moreover, protease
immobilization has been demonstrated to impact plasteinyield. For
instance, immobilizeda-chymotrypsinonhydrophobic agarosegels
and chitinwere found toproducehigher plasteinyields compared to
the free enzyme [26,32,33], although there could be marked
differences in the plastein amino acid composition compared to
the traditionally produced aggregates [33]. Furthermore, plastein
formation can be affected by water activity and matrix interactions
of aggregating peptides with non-protein substances such as
polysaccharides, lipids and salts [8,21,27], as well as the E/S ratio,
proteasemode of action (endo- vs. exoprotease activity) and surface
property of peptides, e.g., hydrophobicity [37].
5. Proposed food applications of plastein
Plastein has been proposed for use in enhancing the nutritional
proﬁle of proteins, and in debittering protein hydrolysates (Table 1)
although these applications are yet to be utilized in the food
Table 1
Potential food and nutraceutical application of plastein.
Potential applications Notes References
Improvement of the nutritional value of proteins Essential amino acids can be incorporated into low-quality proteins by protease-induced plastein
reaction
[4,43,56,58,59]
Enhancement of chemosensory properties of protein
hydrolysates and peptides
Bitterness-contributing hydrophobic amino acid residues can be hidden in the plastein core
thereby limiting interaction with bitter taste receptors
[37,38,43]
Biological activities
Antihypertensive In vitro inhibition of angiotensin I-converting enzyme activity [19,41,53]
Antioxidative In vitro radical scavenging, metal chelating and lipid peroxidation inhibitory activities [47,63]
Cytoprotection against H2O2- and galactosamine-induced damage to rat hepatocyte (BRL) culture [62]
Antithrombotic In vitro inhibition of platelet aggregation (anticoagulation) based on activated partial
thromboplastin and prothrombin time
[60]
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industry. Provided the cost of production is reasonable, these
features (and the thixotropic property) of plastein can be utilized
in enhancing food functionality during food product formulation.
5.1. Enhancement of nutritional quality of food proteins
Plastein reaction can be used to improve nutrient value of food
proteins or unconventional protein sources such as plant or
meat by-products and algae through the incorporation of
essential amino acids. Soy proteins contain low amounts of
sulfur-containing amino acids, Met and Cys and after plastein
reaction with Met there was up to 6-fold higher content of the
amino acid compared to the starting material [28,58]. Feeding
experiment indicated that protein efﬁciency ratio (PER) of the
Met-modiﬁed protein product was 2-fold higher than that of the
unmodiﬁed soy protein in rats [58]. Similar observations were
reported in prawns with a suggestion that the Met in plastein was
more bioavailable than crystalline Met [43]. The increased
bioavailability could be due to the higher absorption rate (via
dedicated peptide transporters) of plastein peptides containing the
supplemental amino acid residues compared to free amino acids.
However, Ashley et al. [2] reported similar PER for Met-modiﬁed
plastein and free Met/protein combination in weanling rats.
Other hydrophobic and hydrophilic amino acids including Trp,
Lys, Glu and Thr have also been successfully incorporated into
zein and soy globulin by plastein reaction [4,56,59]. Despite the
prospects, there is limited interest in commercial utilization of
plastein reaction in enhancing the nutritional quality of proteins,
and this could be due to the cost of the enzymatic processes, low
plastein product yield and availability of alternative proteins with
the desired nutritional quality and functional properties.
5.2. Debittering of protein hydrolysates
Protein hydrolysates are used as emulsifying agents in salad
dressings, spreads, ice cream, coffee whitener and meat products,
and as sources of bioactive peptides for health promotion [35,46].
Hydrolyzed proteins can be bitter due to low-molecular peptides
that are rich in hydrophobic amino acid residues such as Leu, Ile,
Val, Phe, Pro, Tyr and Trp [35]. The hydrophobic amino acid
residues are concentrated in the protein core where they are
mostly inaccessible, but are exposed following enzymatic hydro-
lysis. A list of bitter peptides can be found in BIOPEP database
under “sensory peptides and amino acids” at http://www.uwm.
edu.pl/biochemia/index.php/en/biopep. Bitterness of protein
hydrolysates can negatively impact consumer acceptability of
food products, and can be eliminated by activated carbon
treatment, alcohol extraction, precipitation and chromatography
[35]. However, these methods can lead to loss of important
peptides and functionality of the hydrolysates. Moreover, biotech-
nological methods have been applied in debittering protein
hydrolysates, and this involves the use of endo- and exopeptidases
to remove the amino acid (Pro) residues, that contribute to
bitterness [13,35]. Likewise, structural alterations will occur with
enzymatic debittering potentially leading to loss of the hydrolysate
function. In order to circumvent this limitation, a previous review
discussed the possible use of peptide condensation during plastein
reaction to eliminate bitterness [35], as demonstrated using a
model synthetic peptide system [37]. Moreover, alcalase-induced
plastein was reported to reduce the bitterness of protein hydro-
lysates by 50% [42]. Considering that condensation was found to
rarely occur in complex protein hydrolysates that contain many
peptides and possibly amino acids [37], peptide aggregation
during plastein reaction may be responsible for hiding the
hydrophobic amino acid residues of the hydrolysates from taste
receptors during oral consumption. This may explain the
“insolublematerials” identiﬁed by [37] that contributed to reduced
bitterness. If conﬁrmed, plastein reaction can become a means of
debittering bioactive peptides possibly without loss of structure
and function, which appears to be a challenge in formulating
peptide-based functional foods [45].
6. Reemergence of plastein for potential nutraceutical
application
Bioactive peptides derived from enzymatic hydrolysis of food
proteins are widely pursued as functional food ingredients for
human health promotion [46]. Plastein contains peptides of which
some may be structurally modiﬁed especially if aggregation was
induced by peptide condensation or transpeptidation. In recent
years, the structural modiﬁcations and aggregation that occur
during plastein reaction are thought to lead to alteration of
bioactivity of peptides (Table 1). For instance, plastein reactionwas
reported to increase the angiotensin converting enzyme (ACE)
inhibitory activity of enzymatic protein hydrolysates [19,41,53,61].
Moreover, plastein has been reported to exhibit antioxidative
activity [63], although contrasting observation has been reported
where plastein reaction resulted in loss of metal chelating activity
of casein hydrolysates and no substantial impact on reducing
potential and inhibition of lipid peroxidation [47]. The antiox-
idative property of plastein was implicated in the cytoprotective
activity of Phe- and Tyr-enriched plastein in H2O2- and galactos-
amine-induced damage to cultured rat hepatatocyte; the plastein
increased cell viability and decreased malondialdehyde content
and lactate dehydrogenase leakage associated with the hepatocyte
damage [62]. Furthermore, plastein reaction was reported to
improve the in vitro anticoagulation (inhibition of platelet
aggregation) activity of soybean protein-derived plastein based
on increased activated partial thromboplastin and prothrombin
time [60]. These ﬁndings have added a new perspective to the
application of plastein for the development of health-promoting
products. Despite the prospects, there is a need for validation of the
physiological beneﬁts of plastein using animal models and human
subjects, and to obtain further insight on the structural basis of its
enhanced bioactivity relative to the hydrolysate precursors.
7. Plastein stability
Considering that non-covalent interactions hold the peptides
within plastein, the use of the aggregates in food product
formulation and as nutraceutical is faced with challenges such
as possible instability during food processing and under physio-
logical conditions. Plastein has been found to be stable over a wide
range of acidic and alkaline conditions (pH 2–11) [6] and in boiling
water at 100 C where the aggregate turbidity and bioactivity were
mostly retained [47]. The latter indicates that H-bonds are likely
not involved in plastein stabilization. Therefore, the observed
stability will promote the use of plastein in food formulation under
these pH and temperature conditions.Moreover, Sun and Zhao [41]
suggested that plastein is resistant to proteolysis after gastric
protease treatment, but this conclusion was based on retention of
bioactivity by the protease-treated aggregate. Subsequent evi-
dence demonstrated that casein-derived plastein is disintegrated
and further hydrolyzed bygastric enzymes (pepsin and pancreatin)
based on HPLC proﬁles [47]. This observation potentially limits the
application of plastein aggregates as physiologically relevant
bioactive ingredients as gastric modiﬁcation would lead to loss
of structure and function, similar to the challenges generally faced
in translating peptides into functional products intended for
dietary consumption [45]. That notwithstanding, the conservation
(and sometimes elevation) of bioactivity and elimination
of bitterness observed in plastein compared to hydrolysate
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precursors are promising evidence towarrant further investigation
into their application in the functional food industry.
8. Future direction
It is evident from recent literature that hydrophobic forces play
a major role in peptide aggregation during plastein reaction.
Moreover, this conclusion does not preclude the possible
involvement of condensation and transpeptidation, which can
contribute in rearranging amino acid residues in building
“hydrophobic cores” prior to hydrophobicity-induced peptide
aggregation. As highlighted in this review, the unresolved
formation mechanisms, product heterogeneity and processing
cost factors appear to hinder industrial application of the beneﬁcial
features of plastein in food product development. With the
emerging properties of plastein as bioactive agents, it becomes
imperative to reconsider the value of the peptide aggregates in
food and health applications. In order to circumvent the limitations
on the application of plastein, future work should consider the
following:
1. Understanding the particular role of the proteases during
plastein formation. This information will help in designing
more efﬁcient proteases (by engineering speciﬁc functional
regions of their structures) for production of high yields of
plastein, whichwould potentially lower the cost associatedwith
the enzymatic process.
2. Evaluation of industrial scale-up of the use of immobilized
proteases for protein hydrolysis and plastein formation. If
successful, this processwill facilitate easy recovery and repeated
usage of the proteases, and potentially lower the cost of
commercial production of plastein.
Furthermore, a number of opportunities are presented by
plastein reaction and these can be explored in different applica-
tions including:
1. Elimination of amino acid and peptide-induced bitterness
associatedwith enzymatic processing ormicrobial fermentation
of plant-based and meat products intended for oral consump-
tion by humans and animals (e.g., pet foods, nutraceuticals);
2. Entrapment of bioactive compounds and ﬂavoring agents within
the plastein matrix for efﬁcient delivery in food products;
3. Utilization of the gel-like properties of plastein as thickening
factors in the formulation of food products with acceptable
sensory properties.
Acknowledgement
Financial support from the Natural Sciences and Engineering
Research Council of Canada (NSERC) is acknowledged.
References
[1] A.T. Andrews, E. Alichanidis, The plastein reaction revisited: evidence for a
purely aggregation reaction mechanism, Food Chem. 35 (4) (1990) 243–261.
[2] D.V.M. Ashley, R. Temler, D. Barclay, C.A. Dormond, R. Jost, Amino acid-
enriched plasteins: a source of limiting amino acids for the weanling rat, J.
Nutr. 113 (1) (1983) 21–27.
[3] K. Aso, M. Yamashita, S. Arai, M. Fujimaki, Hydrophobic force as a main factor
contributing to plastein chain assembly, J. Biochem. 76 (2) (1974) 341–347.
[4] K. Aso, M. Yamashita, S. Arai, M. Fujimaki, Tryptophan-, threonine-, and lysine-
enriched plasteins from zein, Agric. Biol. Chem. 38 (3) (1974) 679–680.
[5] H.H. Beard, The nutritive value of plastein, J. Biol. Chem. 71 (2) (1927) 477–480.
[6] V.L. Brownsell, R.J.H.Williams, A.T. Andrews, Applicationof the plastein reaction
to mycoprotein: II. Plastein properties, Food Chem. 72 (3) (2001) 337–346.
[7] J.A.V. Butler, E.C. Dodds, D.M.P. Phillips, J.M.L. Stephen, The action of pepsin on
insulin and the plastein question, Biochem. J. 42 (1) (1948) 122.
[8] D. Combes, P. Lozano,a-Chymotrypsin in plastein synthesis inﬂuence of water
activity, Ann. N. Y. Acad. Sci. 672 (1) (1992) 409–414.
[10] D. Doucet, S.F. Gauthier, D. Otter, E.A. Foegeding, Enzyme-induced gelation of
extensively hydrolyzed whey proteins by alcalase: comparison with the
plastein reaction and characterization of interactions, J. Agric. Food Chem. 51
(2003) 6036–6042.
[11] J.H. Edwards, W.F. Shipe, Characterization of plastein reaction products
formed by pepsin, a-chymotrypsin, and papain treatment of egg albumin
hydrolysates, J. Food Sci. 43 (4) (1978) 1215–1218.
[12] S. Eriksen, I.S. Fagerson, The plastein reaction and its applications: a review,
J. Food Sci. 41 (3) (1976) 490–493.
[13] R.J. FitzGerald, G. O'Cuinn, Enzymatic debittering of food protein hydrolysates,
Biotechnol. Adv. 24 (2) (2006) 234–237.
[14] E.W. Flosdorf, S. Mudd, E.W. Flosdorf, The apparent antigenicity of plastein,
J. Immunol. 32 (1937) 441–450.
[15] S.J. Folley, The nature of plastein, Biochem. J. 26 (1932) 99–105.
[16] M. Fujimaki, S. Arai,M. Yamashita, Enzymatic protein degradation and synthesis
for protein improvement, Adv. Chem. Ser. 160 (1977) 156–184.
[17] M. Fujimaki, H. Kato, S. Arai, M. Yamashita, Application of microbial proteases
to soybean and other materials to improve acceptability, especially through
the formation of plastein, J. Appl. Bacteriol. 34 (1) (1971) 119–131.
[18] M. Fujimaki, M. Yamashita, S. Arai, H. Kato, Enzymic modiﬁcation of proteins
in foodstuffs. I. Enzymic proteolysis and plastein synthesis application
for preparing bland protein-like substrance, Agric. Biol. Chem. 34 (9) (1970)
1325–1332.
[19] B. Gao, X.H. Zhao, Modiﬁcation of soybean protein hydrolysates by alcalase-
catalyzed plastein reaction and the ACE-inhibitory activity of the modiﬁed
product in vitro, Int. J. Food Prop. 15 (5) (2012) 982–996.
[20] A. Goepfert, P.C. Lorenzen, E. Schlimme, Peptide synthesis during in vitro
proteolysis-transpeptidation or condensation? Food/Nahrung 43 (3) (1999)
211–212.
[21] R.C. Hagan, R. Villota, Effects of nonprotein substances on protein hydrolysis
and plastein formation, Food Chem. 23 (4) (1987) 277–294.
[22] E.K. Hartnett, L.D. Satterlee, The formation of heat and enzyme induced
(plastein) gels from pepsin-hydrolyzed soy protein isolate, J. Food Biochem.14
(1) (1990) 1–13.
[23] J. Horowitz, F. Haurowitz, Mechanism of plastein formation, Biochim. Biophys.
Acta 33 (1) (1959) 231–237.
[24] J.S. Hyung, H. Lee, Y.C. Hong, C.Y. Han, Production of protein hydrolysates
and plastein from Alaska pollock, Korean Agric. Chem. Soc. 35 (5) (1992)
339–345.
[25] M. Kantola, A.I. Virtanen, X-ray diagram of plastein, Acta Chem. Scand. 4 (8)
(1950) 1314–1315.
[26] I. Karube, Y. Yugeta, S. Suzuki, Plastein synthesis by a-chymotrypsin
immobilized on hydrophobic agarose gel, J. Mol. Catal. 9 (4) (1980) 445–451.
[27] P. Lozano, D. Combes, Effect of alkali halides on a-chymotrypsin activity in the
plastein reaction, J. Sci. Food Agric. 62 (3) (1993) 245–252.
[28] J.C. Monti, R. Jost, Papain-catalyzed synthesis of methionine-enriched soy
plasteins. Average chain length of the plasteinpeptides, J. Agric. Food Chem. 27
(6) (1979) 1281–1285.
[29] J.H. Northrop, Plastein from pepsin and trypsin, J. Gen. Physiol. 30 (1947)
377–378.
[30] S. Ono, D. Kasai, T. Sugano, K. Ohba, K. Takahashi, Production of water soluble
antioxidative plastein from squid hepatopancreas, J. Oleo Sci. 53 (5) (2004)
267–273.
[31] Y. Onoue, V.M. Riddle, Use of plastein reaction in recovering protein from ﬁsh
waste, J. Fish. Board Can. 30 (11) (1973) 1745–1747.
[32] C. Pallavicini, J.W. Finley, W.L. Stanley, G.G. Watters, Plastein synthesis with
a-chymotrypsin immobilised on chitin, J. Sci. FoodAgric. 31 (3) (1980) 273–278.
[33] C. Pallavicini, A.D.B. Peruffo, J.W. Finley, Comparative study of soybean
plasteins synthesized with soluble and immobilized alpha-chymotrypsin,
J. Agric. Food Chem. 31 (4) (1983) 846–848.
[34] M.R. Raghunath, A.R. McCurdy, Synthesis of plasteins from ﬁsh silage, J. Sci.
Food Agric. 54 (4) (1991) 655–658.
[35] B.C. Saha, K. Hayashi, Debittering of protein hydrolyzates, Biotechnol. Adv. 19
(5) (2001) 355–370.
[36] V.A. Savangikar, R.N. Joshi, Modiﬁcation of leaf protein concentrate by the use
of plastein reaction, J. Sci. Food Agric. 30 (9) (1979) 899–905.
[37] D.E. Stevenson, K.R. Morgan, G.A. Fenton, G. Moraes, Use of NMR and mass
spectrometry to detect and quantify protease-catalyzed peptide bond
formation in complex mixtures, Enzyme Microb. Technol. 25 (3) (1999)
357–363.
[38] D.E. Stevenson, D.J. Ofman, K.R. Morgan, R.A. Stanley, Protease-catalyzed
condensation of peptides as a potential means to reduce the bitter taste of
hydrophobic peptides found in protein hydrolysates, EnzymeMicrob. Technol.
22 (1998) 100–110.
[39] G. Sukan, A.T. Andrews, Application of the plastein reaction to caseins and to
skim-milk powder: I. Protein hydrolysis and plastein formation, J. Dairy Res. 49
(2) (1982) 265–278.
[40] G. Sukan, A.T. Andrews, Application of the plastein reaction to caseins and to
skim-milk powder: II. Chemical and physical properties of the plasteins and
the mechanism of plastein formation, J. Dairy Res. 49 (1982) 279–293.
[41] H. Sun, X.H. Zhao, Angiotensin I converting enzyme inhibition and enzymatic
resistance in vitro of casein hydrolysate treated by plastein reaction and
fractionated with ethanol/water or methanol/water, Int. Dairy J. 24 (1) (2012)
27–32.
68 M. Gong et al. / Biotechnology Reports 5 (2015) 63–69
[42] J. Synowiecki, R. Jagietka, F. Shahidi, Preparation of hydrolysates from bovine
red blood cells and their debittering following plastein reaction, Food Chem.
57 (3) (1996) 435–439.
[43] S. Teshima, A. Kanazawa, S. Koshio, Supplemental effects of methionine-
enriched plastein in Penaeus japonicas diets, Aquaculture 101 (1) (1992) 85–93.
[44] S.-J. Tsai, M. Yamashita, S. Arai, M. Fujimaki, Effect of substrate concentration
on plastein productivity and some rheological properties of the products, Agr.
Biol. Chem. 36 (1972) 1045.
[45] C.C. Udenigwe, Bioinformatics approaches, prospects and challenges of food
bioactive peptide research, Trends Food Sci. Technol. 36 (2) (2014) 137–143.
[46] C.C. Udenigwe, R.E. Aluko, Food protein-derived bioactive peptides:
production, processing, and potential health beneﬁts, J. Food Sci. 77 (1)
(2012) R11–R24.
[47] C.C. Udenigwe, S. Wu, K. Drummond, M. Gong, Revisiting the prospects of
plastein: thermal and simulated gastric stability in relation to the
antioxidative capacity of casein plastein, J. Agric. Food Chem. 62 (1) (2014)
130–135.
[48] B. Van Hofsten, G. Lalasidis, Protease-catalyzed formation of plastein products
and some of their properties, J. Agric. Food Chem. 24 (1976) 460–465.
[49] A.I. Virtanen, H.K. Kerkkonen, T. Laaksonen, Obesrvations on the formation and
structure of pla3, Acta Chem. Scand. 2 (10) (1948) 933–935.
[50] H. Wasteneys, H. Borsook, The enzymatic synthesis of protein. II. The effect of
temperature on the synthesizing action of pepsin, J. Biol. Chem. 62 (1924)
15–29.
[51] H. Wasteneys, H. Borsook, The enzymatic synthesis of protein, Physiol. Rev. 10
(1930) 110–145.
[52] R.J.H.Williams,V.L. Brownsell, A.T. Andrews, Application of theplastein reaction
to mycoprotein: I. Plastein synthesis, Food Chem. 72 (3) (2001) 329–335.
[53] W. Xu, B.H. Kong, X.H. Zhao, Optimization of some conditions of neutrase-
catalyzed plastein reaction tomediate ACE-inhibitory activity in vitro of casein
hydrolysate prepared by Neutrase, Food Sci. Technol. 51 (2) (2014) 276–284.
[54] M. Yamashita, S. Arai, S. Tanimoto, et al., Condensation reaction occurring
during plastein formation by a-chymotrypsin, Agric. Biol. Chem. 37 (4) (1973)
953–954.
[55] M. Yamashita, S. Arai, M. Fujimaki, Plastein reaction for food protein
improvement, J. Agric. Food Chem. 24 (6) (1976) 1100–1104.
[56] M. Yamashita, S. Arai, S. Kokubo, K. Aso, M. Fujimaki, Synthesis and
characterization of a glutamic acid enriched plastein with greater solubility,
J. Agric. Food Chem. 23 (1) (1975) 27–30.
[57] M. Yamashita, S. Arai, S.J. Tsai, M. Fujimaki, Supplementing sulfur-containing
amino acids by plastein reaction, Agric. Biol. Chem. 34 (10) (1970) 1593–1596.
[58] M. Yamashita, S. Arai, S.-J. Tsai, M. Fujimaki, Plastein reaction as a method for
enhancing the sulfur-containing amino acid level of soybean protein, J. Agric.
Food Chem. 19 (1971) 1151T.
[59] M. Yamashita, S. Arai, S. Kokubo, K. Aso, M. Fujimaki, A plastein with an
extremely high amount of glutamic acid, Agric. Biol. Chem. 38 (1974) 1269.
[60] M.L. Zhang, X.H. Zhao, In vitro calcium-chelating and platelet anti-aggregation
activities of soy protein hydrolysate modiﬁed by the alcalase-catalyzed
plastein reaction, J. Food Biochem. 38 (3) (2014) 374–380.
[61] X.H. Zhao, Y.Y. Li, An approach to improve ACE-inhibitory activity of casein
hydrolysates with plastein reaction catalyzed by alcalase, Eur. Food Res.
Technol. 229 (5) (2009) 795–805.
[62] X.H. Zhao, Y. Fu, N. Yue, In vitro cytoprotection of modiﬁed casein hydrolysates
by plastein reaction on rat hepatocyte cells, CyTA-J. Food 12 (1) (2014) 40–47.
[63] X.H. Zhao, D. Wu, T.J. Li, Preparation and radical scavenging activity of
papain-catalyzed casein plasteins, Dairy Sci. Technol. 90 (5) (2010) 521–535.
M. Gong et al. / Biotechnology Reports 5 (2015) 63–69 69
